Ablation of the entire prostate gland.
92% of patients are successfully treated.
Over 99% of men remain continent.
70% of men retain erectile function.
Targeted only to the area in the prostate gland where the tumor is located.
95% of patients maintained potency.
89% of men achieved “the trifecta status” (pad-free, leak-free continence, erections sufficient for intercourse and cancer control at 12 months).
Short procedure time (20-90 minutes).
Option for patients with a recurrence of prostate cancer.
71% biochemical disease free rate.
93% of patients remain continent.